Robert R. Redfield, the former Director of the Centers for Disease Control and Prevention (CDC) during the Trump administration, testified before a government committee, emphasizing the need for enhanced oversight of U.S. taxpayer-funded high-risk viral research. Redfield, who oversaw the CDC's response to the COVID-19 pandemic, highlighted his extensive background in virology and public health, including over 20 years as a U.S. Army physician and his role in founding the Institute of Human Virology at the University of Maryland.

In his statement, Redfield expressed strong support for the proposed bill aimed at addressing the disconnect between biomedical research funding and national security interests. He underscored that biosecurity represents a significant threat to national security, a concern that he believes is often overlooked by biomedical researchers when making funding decisions.

Redfield's testimony comes at a critical time as the government seeks to reassess its approach to funding and oversight in the wake of the pandemic, aiming to ensure that future research aligns more closely with the nation's security needs. His call for increased vigilance in the realm of biosecurity reflects a growing recognition of the potential risks associated with high-risk viral research.